Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fridrich

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Schweizerische Medizinische Wochenschrift|November 2, 1991
[Risk assessment in diagnostic radiation dosimetry]R Fridrich
Strahlentherapie|July 1, 1977
[Radioprotection during clinical and laboratory utilization of tritium-labeled thymidine (author's transl)]H Renner, R Fridrich
Nuklearmedizin. Nuclear Medicine|July 1, 1977
[Retention and dosage in radiation synovectomy with yttrium-90-silicate colloid]H W Nemec, R Fridrich
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1988
[Nuclear medicine: current aspects and future]R Fridrich, J Müller-Brand
Schweizerische Medizinische Wochenschrift|December 1, 1984
[Ventilation scintigraphy with 127Xenon gas--efficient use for emergency diagnosis of pulmonary embolism]J Müller-Brand, R Fridrich
Radiologia Clinica|January 1, 1975
[Pretherapeutic evaluation of bone matastases in patients with potentially curable breast cancer (author's transl)]R Sauer, H Hartweg, R Fridrich
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1984
Antianginal drug effects on normal, ischemic and scar myocardial segments in manM Pfisterer, R Fridrich, F Burkart
Experientia|June 15, 1984
The in vitro stability in human plasma of two different technetium-99m-fibrinogen compoundsE Spicher, B Gieux, R Fridrich
Scandinavian Journal of Rheumatology|January 1, 1975
Treatment of chronic articular effusions with 90-yttrium (90Y)W Müller, K Pavelka, R Fridrich
Thrombosis Research|November 1, 1982
Some chemical aspects of labeling human fibrinogen with 99m-technetiumM Kirstein, R Fridrich, H Seiler
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Schweizerische Medizinische Wochenschrift|November 2, 1991
[Risk assessment in diagnostic radiation dosimetry]R Fridrich
Strahlentherapie|July 1, 1977
[Radioprotection during clinical and laboratory utilization of tritium-labeled thymidine (author's transl)]H Renner, R Fridrich
Nuklearmedizin. Nuclear Medicine|July 1, 1977
[Retention and dosage in radiation synovectomy with yttrium-90-silicate colloid]H W Nemec, R Fridrich
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1988
[Nuclear medicine: current aspects and future]R Fridrich, J Müller-Brand
Schweizerische Medizinische Wochenschrift|December 1, 1984
[Ventilation scintigraphy with 127Xenon gas--efficient use for emergency diagnosis of pulmonary embolism]J Müller-Brand, R Fridrich
Radiologia Clinica|January 1, 1975
[Pretherapeutic evaluation of bone matastases in patients with potentially curable breast cancer (author's transl)]R Sauer, H Hartweg, R Fridrich
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1984
Antianginal drug effects on normal, ischemic and scar myocardial segments in manM Pfisterer, R Fridrich, F Burkart
Experientia|June 15, 1984
The in vitro stability in human plasma of two different technetium-99m-fibrinogen compoundsE Spicher, B Gieux, R Fridrich
Scandinavian Journal of Rheumatology|January 1, 1975
Treatment of chronic articular effusions with 90-yttrium (90Y)W Müller, K Pavelka, R Fridrich
Thrombosis Research|November 1, 1982
Some chemical aspects of labeling human fibrinogen with 99m-technetiumM Kirstein, R Fridrich, H Seiler
Pageof 6